Top Back to top

Bone marrow aplasia after CD19 CAR T-Cell therapy: a retrospective study from the EBMT Transplant Complications Working Party

Transplant Complications Working Party (TCWP)
Study type:
Study number:
 
Type of Stem Cell Treatment:
CAR T
Diseases:
 
Short title:
 
Primary objective:
Investigate the incidence of bone marrow aplasia and its clinical impact after therapy with commercial CD19 CAR-T cell products.
Key inclusion criteria:
Investigate the incidence of bone marrow aplasia and its clinical impact after therapy with commercial CD19 CAR-T cell products.
Country:
 
Principal investigator:
Olaf Penack